aTyr Pharma ATYR Q1 2026 Earnings Beat Revenue NA EPS 011 BEL Shares Dip Over 2 Despite Strong Q4 Results Goldman Sachs and Nomura Weigh In Amgen Price Target Reduced at Piper Sandler but LongTerm Outlook Remains Positive Phibro PAHC Crushes Q1 2026 Estimates EPS 076 Tops Views